UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer

The oncologist (Dayton, Ohio), 2024-06, Vol.29 (9), p.e1228-e1230

2024

Volltextzugriff (PDF)

Value of next generation sequencing (NGS) testing in advanced cancer patients

Journal of medical economics, 2024, Vol.27 (1), p.519-530

2024

Volltextzugriff (PDF)

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

The American Journal of Medicine, 2004-04, Vol.116 (8), p.546-554

2004

Volltextzugriff (PDF)

219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A250-A250

2023

Volltextzugriff (PDF)

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

Cancer, 2006-12, Vol.107 (11), p.2609-2616

2006

Volltextzugriff (PDF)

Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit

Cancer, 2008-05, Vol.112 (10), p.2233-2240

2008

Volltextzugriff (PDF)

Expression of bcl-2 in Classical Hodgkin's Lymphoma: An Independent Predictor of Poor Outcome

Journal of clinical oncology, 2005-06, Vol.23 (16), p.3773-3779

2005

Volltextzugriff (PDF)

ESR1 alterations in gynecologic cancers

Gynecologic oncology, 2024-11, Vol.190, p.S148-S148

2024

Volltextzugriff (PDF)

Oncogenic fusions in renal cell carcinoma

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.475-475

2024

Volltextzugriff (PDF)

Genomic profiling of biliary tract carcinomas by their location

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16175-e16175

2023

Volltextzugriff (PDF)

The genomic landscape of TERT alterations in bladder cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.551-551

2023

Volltextzugriff (PDF)

Erythroblast transformation-specific transcription factor fusions in prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.224-224

2023

Volltextzugriff (PDF)

BRAF mutation classes and co-occurring mutations in NSCLC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9083-9083

2022

Volltextzugriff (PDF)

Prevalence and genomic landscape of BRAF alterations across gastrointestinal cancers

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.806-806

2023

Volltextzugriff (PDF)

CGE23-072: The Frequency of Androgen Receptor Splice Variant 7 (AR-V7) in Solid Tumors

Journal of the National Comprehensive Cancer Network, 2023-03, Vol.21 (3.5), p.CGE23-072

2023

Volltextzugriff (PDF)

Comprehensive whole-exome and transcriptome profiling to identify actionable alterations associated with response to PARP inhibitors in breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1096-1096

2022

Volltextzugriff (PDF)

Molecular profiling to identify potential therapeutic targets in hepatocellular carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.471-471

2022

Volltextzugriff (PDF)

Age-associated mutations in RAS -mutated versus RAS- nonmutated metastatic colorectal cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.171-171

2022

Volltextzugriff (PDF)

Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics

Current oncology reports, 2006-04, Vol.8 (2), p.108-113

2006

Volltextzugriff (PDF)

Abstract A070: Genomic profiling of pancreatic cancer by KRAS status

Cancer research (Chicago, Ill.), 2024-01, Vol.84 (2_Supplement), p.A070-A070

2024

Volltextzugriff (PDF)

Intimal pulmonary artery sarcoma presenting as dyspnea: case report

International seminars in surgical oncology, 2007-06, Vol.4 (14), p.14-14, Article 14

2007

Volltextzugriff (PDF)

Abstract 2150: CLDN18/ARHGAP26 fusions in gastric cancers

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2150-2150

2023

Volltextzugriff (PDF)

Comprehensive genomic profiling to identify gene alterations in DNA repair pathway across solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3124-3124

2022

Volltextzugriff (PDF)

Abstract PO5-13-06: Classifying HER2-low breast cancer using a combination of ERBB2 mRNA expression and altered genes

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO5-13-06-PO5-13-06

2024

Volltextzugriff (PDF)

Abstract PO5-13-05: Comparison of whole exome, whole transcriptome genomic profiling and targeted sequencing with 50-gene panels

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO5-13-05-PO5-13-05

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(10)
Humans
(9)
Computer Science
(6)
Male
(6)
Oncology
(6)
Biological And Medical Sciences
(5)
Female
(5)
Medical Sciences
(5)
Technology
(5)
Information Systems -- Information Systems Applications -- Spatial-Temporal Systems
(4)
Middle Aged
(4)
Prognosis
(4)
Software
(4)
Tumors
(4)
Adult
(3)
Aged
(3)
Applied Sciences
(3)
Computer Science, Artificial Intelligence
(3)
Computer Science; Control Theory; Systems
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer

Value of next generation sequencing (NGS) testing in advanced cancer patients

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit

Expression of bcl-2 in Classical Hodgkin's Lymphoma: An Independent Predictor of Poor Outcome

ESR1 alterations in gynecologic cancers

Oncogenic fusions in renal cell carcinoma

Genomic profiling of biliary tract carcinomas by their location

The genomic landscape of TERT alterations in bladder cancer

Erythroblast transformation-specific transcription factor fusions in prostate cancer

BRAF mutation classes and co-occurring mutations in NSCLC

Prevalence and genomic landscape of BRAF alterations across gastrointestinal cancers

CGE23-072: The Frequency of Androgen Receptor Splice Variant 7 (AR-V7) in Solid Tumors

Comprehensive whole-exome and transcriptome profiling to identify actionable alterations associated with response to PARP inhibitors in breast cancer

Molecular profiling to identify potential therapeutic targets in hepatocellular carcinoma

Age-associated mutations in RAS -mutated versus RAS- nonmutated metastatic colorectal cancer

Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics

Abstract A070: Genomic profiling of pancreatic cancer by KRAS status

Intimal pulmonary artery sarcoma presenting as dyspnea: case report

Abstract 2150: CLDN18/ARHGAP26 fusions in gastric cancers

Comprehensive genomic profiling to identify gene alterations in DNA repair pathway across solid tumors

Abstract PO5-13-06: Classifying HER2-low breast cancer using a combination of ERBB2 mRNA expression and altered genes

Abstract PO5-13-05: Comparison of whole exome, whole transcriptome genomic profiling and targeted sequencing with 50-gene panels

Suchergebnisse filtern